ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconFacebook IconIcon FacebookGoogle Plus IconLayer 1InstagramCreated with Sketch.Linkedin IconIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerIcon Opinion QuotePositive ArrowIcon PrintRSS IconIcon SearchSite TitleTitle ChevronTwitter IconIcon TwitterYoutube Icon
Consumer Non-Durables

Ajinomoto Co., Inc.

  • 2,059.00 JPY
  • -13.00
  • -0.63%
  • Japan
    Jun 22, 2018
  • Ticker
    TKS(2802)
  • Prev. close
    2,072
  • Market cap (JPY)
    1,184.90B
  • Market cap (USD)
    10,760.10M
  • Shares
    571.86M

Business Summary

Ajinomoto Co., Inc. engages in the manufacture, distribution, and sale of food products, amino acids, and pharmaceuticals. It operates through the following segments: Domestic Food Products, Overseas Food Products, Life Support, Healthcare and Others. The Domestic Food Products segment includes seasonings and processed foods, and frozen foods. The Overseas Food Products segment provides consumer foods, which include flavor seasonings and instant noodles; and umami seasonings for processed food manufacturers. The Life Support segment offers feed-use amino acids, amino acids for pharmaceuticals and foods, sweeteners, pharmaceutical fine chemicals, and specialty chemicals. The Healthcare segment handles medical foods and pharmaceuticals. The Others segment covers the packaging materials business, healthcare business, partnership business, logistics, and other services. The company was founded by Saburosuke Suzuki II on May 20, 1909 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2018 JPYUSD
Revenue1,150.20B10,377.91M
Gross Profit397,430M3,585.86M
Operating income93,342M842.19M
Income before tax85,445M770.93M
Net income60,742M548.05M
EBITDA145,125M1,309.40M
Diluted EPS106.840.96
Dividends Per Share320.28
Total Assets1,425.85B13,407.22M
Total liabilities705,308M6,631.94M
Total equity641,445M6,031.45M
Operating cash flow126,655M1,142.76M
Currency in JPYCurrency in USD

Historical Data

 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 991,332M 1,006.63B 1,149.42B 1,091.19B 1,150.20B
Gross Profit 344,462M 335,392M 377,368M 374,412M 397,430M
Operating income 62,548M 74,519M 95,816M 87,130M 93,342M
Income before tax 73,302M 79,049M 98,778M 86,684M 85,445M
Net income 42,795M 46,495M 68,504M 53,065M 60,742M
EBITDA 109,883M 120,096M 147,680M 133,782M 145,125M
Diluted EPS 69.70 78.54 121.23 92.81 106.84
Dividends Per Share 20 24 28 30 32
Total Assets 1,091.65B 1,255.09B 1,273.89B 1,350.10B 1,425.85B
Total liabilities 432,163M 511,601M 593,161M 659,428M 705,308M
Total equity 598,925M 669,576M 609,486M 616,315M 641,445M
Operating cash flow 63,017M 109,259M 129,311M 108,907M 126,655M
 Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Revenue 9,896.34M 9,163.13M 9,571.83M 10,076.83M 10,377.91M
Gross Profit 3,438.72M 3,053.00M 3,142.52M 3,457.57M 3,585.86M
Operating income 624.40M 678.33M 797.90M 804.61M 842.19M
Income before tax 731.76M 719.56M 822.57M 800.49M 770.93M
Net income 427.21M 423.23M 570.46M 490.03M 548.05M
EBITDA 1,096.94M 1,093.20M 1,229.80M 1,235.43M 1,309.40M
Diluted EPS 0.69 0.71 1.00 0.85 0.96
Dividends Per Share 0.19 0.21 0.23 0.27 0.28
Total Assets 10,600.08M 10,465.62M 11,334.07M 12,116.17M 13,407.22M
Total liabilities 4,196.36M 4,266.00M 5,277.46M 5,917.86M 6,631.94M
Total equity 5,815.65M 5,583.28M 5,422.71M 5,530.96M 6,031.45M
Operating cash flow 629.09M 994.56M 1,076.83M 1,005.72M 1,142.76M

Valuation Measures

Mar 2018
PER18.01
ROA4.37%
ROE9.65%
Operating margin8.11%
Profit margin5.28%

Key executives

  • President, CEO & Representative Director: Takaaki Nishii
  • Manager-Research & Development Planning: Kazuya Onomichi
  • Representative Director & Executive Vice President: Tamotsu Iwamoto
  • Executive Officer: Chiaki Nosaka
  • Executive Officer & Manager-Human Resources: Yoshimasa Yoshimiya

Shareholders

  • Mitsubishi UFJ Financial Group, Inc. (5.5%)
  • Dai-ichi Life Holdings, Inc. (4.5%)
  • Nippon Life Insurance Co. (4.4%)
  • Nomura Asset Management Co., Ltd. (4.0%)
  • BlackRock Fund Advisors (3.0%)
  • Nikko Asset Management Co., Ltd. (2.4%)
  • Meiji Yasuda Life Insurance Co. (2.2%)
  • The Vanguard Group, Inc. (2.1%)
  • BlackRock Japan Co., Ltd. (1.9%)
  • Mizuho Financial Group, Inc. (1.7%)

Contact Details

Related Companies

  • Ajinomoto Foods North America, Inc.
  • Ajinomoto Board Incentive Plan
  • Delica Ace Corp.
  • Ajinomoto Bakery Co., Ltd.
  • Orgen Gida Sanayi Ve Ticaret AS
  • Ace Pack (Thailand) Co. Ltd.
  • Althea SARL
  • Ajinomoto Phlippines Global Food, Inc.
  • Ajinomoto SEA Regional Headquarters Co. Ltd.
  • Si Ayutthaya Real Estate Co. Ltd.
  • Amoy North America, Inc.
  • Shenzhen Amoy Foods Co. Ltd.
  • FD Green (Thailand) Co. Ltd.
  • Xiamen Ajinomoto Life Ideal Foods Co. Ltd.
  • Shanghai Ajinomoto Food Research & Development Center Co. Ltd.
  • Ajinomoto (Cambodia) Co. Ltd.
  • Ajinomoto Istanbul Food Sales Ltd.
  • Ajinomoto Frozen Foods (Thailand) Co. Ltd.
  • Ajinomoto Animal Nutrition (Singapore) Pte Ltd.
  • Lianyungang Ajinomoto Frozen Foods Co. Ltd.
  • Lianyungang Ajinomoto Ruyi Foods Co. Ltd.
  • GeneDesign, Inc.
  • PT Ajinex International
  • Ajinomoto India Pvt Ltd.
  • Ajinomoto de Mexico S de RL de CV
  • Henan Ajinomoto Amino Acid Co. Ltd.
  • Shanghai Ajinomoto Seasoning Co. Ltd.
  • Ajinomoto Co. (Hong Kong) Ltd.
  • Ajinomoto Sales (Thailand) Co. Ltd.
  • Ajinomoto Bangladesh Ltd.

Competitors

  • Evonik Industries AG
  • Star Lake Bioscience Co., Inc. Class A
  • MeiHua Holdings Group Co Ltd. Class A
  • CJ Corporation
  • Mitsubishi Corporation
  • Daesang Corporation
  • CJ CheilJedang Corporation
  • Archer-Daniels-Midland Company
  • Fufeng Group Limited
  • Global Bio-chem Technology Group Co. Ltd.
  • Vedan International (Holdings) Ltd.
  • Nichirei Corporation
  • KENKO Mayonnaise Co., Ltd.
  • Grupo Bimbo SAB de CV Class A
  • Emergent BioSolutions Inc.
  • Japan Tobacco Inc.
  • Celanese Corporation Class A
  • Senomyx, Inc.
  • Versartis, Inc.
Last Updated on 22 Jun, 2018

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

Get unlimited access
NAR site on phone, device, tablet

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

3 months for $9

Get unlimited access
NAR site on phone, device, tablet

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media